logo
CORONARY FLOW RESERVE IN CARDIAC ALLOGRAFT VASCULOPATHY
DETOXIFYING ACTIVITY IN PIG LIVERS AND HEPATOCYTES INTENDED FOR XENOTHERAPY1
LONG-TERM MYOCARDIAL PRESERVATION
EFFECT OF ISLET TRANSPLANTATION ON NEUROELECTROPHYSIOLOGICAL ABNORMALITIES IN DIABETIC INBRED LEWIS RATS: COMPARISON OF PRIMARY VERSUS SECONDARY PREVENTION1
NEUTROPHIL ELASTASE AND OXYGEN RADICALS ENHANCE MONOCYTE CHEMOATTRACTANT PROTEIN-1 EXPRESSION AFTER ISCHEMIA/REPERFUSION IN RAT LIVER
IDENTIFICATION OF KIDNEYS SUBJECTED TO PRERETRIEVAL WARM ISCHEMIC INJURY BY SIMULTANEOUS MONITORING OF GLOMERULAR FILTRATION AND PERFUSATE FLOW DURING HYPOTHERMIC PERFUSION PRESERVATION
CEREBROVASCULAR METABOLIC AUTOREGULATION IS IMPAIRED DURING LIVER TRANSPLANTATION1
PREDICTORS OF REDUCED CORONARY FLOW RESERVE IN HEART TRANSPLANT RECIPIENTS WITHOUT ANGIOGRAPHICALLY SIGNIFICANT CORONARY ARTERY DISEASE
DIFFERENCES IN GASTRIC MOTOR ACTIVITY IN RENAL TRANSPLANT RECIPIENTS TREATED WITH FK-506 VERSUS CYCLOSPORINE
THE ROLE OF HEPATITIS C AND B VIRUS INFECTIONS AS RISK FACTORS FOR SEVERE LIVER COMPLICATIONS FOLLOWING ALLOGENEIC BMT: A PROSPECTIVE STUDY BY THE INFECTIOUS DISEASE WORKING PARTY OF THE EUROPEAN BLOOD AND MARROW TRANSPLANTATION GROUP1
OBESE LIVING KIDNEY DONORS: SHORT-TERM RESULTS AND POSSIBLE IMPLICATIONS1
INFECTIOUS COMPLICATIONS IN GERIATRIC RENAL TRANSPLANT PATIENTS
FAMCICLOVIR TREATMENT OF CHRONIC HEPATITIS B IN HEART TRANSPLANT RECIPIENTS: A PROSPECTIVE TRIAL1,2
QUANTIFICATION OF SERUM HCV CORE ANTIGEN BY A FLUORESCENT ENZYME IMMUNOASSAY IN LIVER TRANSPLANT RECIPIENTS WITH RECURRENT HEPATITIS C-CLINICAL AND VIROLOGIC IMPLICATIONS1
EPSTEIN-BARR VIRUS-INDUCED POSTTRANSPLANT LYMPHOPROLIFERATIVE DISORDERS
SIROLIMUS REDUCES THE INCIDENCE OF ACUTE REJECTION EPISODES DESPITE LOWER CYCLOSPORINE DOSES IN CAUCASIAN RECIPIENTS OF MISMATCHED PRIMARY RENAL ALLOGRAFTS: A PHASE II TRIAL1
THE EFFECTS OF MAINTENANCE DOSES OF FK506 VERSUS CYCLOSPORIN A ON GLUCOSE AND LIPID METABOLISM AFTER ORTHOTOPIC LIVER TRANSPLANTATION1
SUSCEPTIBILITY OF LUNG TRANSPLANTS TO PREFORMED DONOR-SPECIFIC HLA ANTIBODIES AS DETECTED BY FLOW CYTOMETRY
A STUDY OF CYTOKINE PROTEIN SECRETION, FREQUENCIES OF CYTOKINE EXPRESSING CELLS AND IFN-G GENE POLYMORPHISMS IN NORMAL INDIVIDUALS1
HUMAN T CELL RESPONSES TO HUMAN AND PORCINE ENDOTHELIAL CELLS ARE HIGHLY SENSITIVE TO CYCLOSPORIN A AND FK506 IN VITRO1
INFLUENCE OF THE ADDITIONAL INJECTION OF HOST-TYPE BONE MARROW ON THE IMMUNE TOLERANCE OF MINOR ANTIGEN-MISMATCHED CHIMERAS
STRAIN SPECIFIC EFFECTS OF CYTOMEGALOVIRUS ON ENDOTHELIAL CELLS: IMPLICATIONS FOR INVESTIGATING THE RELATIONSHIP BETWEEN CMV AND CARDIAC ALLOGRAFT VASCULOPATHY1
DONOR-TYPE CHIMERISM DETERMINATION BY COMPETITIVE POLYMERASE CHAIN REACTION (PCR) IN A PRIMATE MODEL FOR BONE MARROW TRANSPLANTATION1
CLINICALLY STABLE HUMAN RENAL ALLOGRAFTS CONTAIN HISTOLOGICAL AND RNA-BASED FINDINGS THAT CORRELATE WITH DETERIORATING GRAFT FUNCTION1,2
PENTOSAN POLYSULFATE TREATMENT REDUCES CYCLOSPORINE-INDUCED NEPHROPATHY IN SALT-DEPLETED RATS1
SELECTIVE DELETION OF ANTIGEN-SPECIFIC, ACTIVATED T CELLS BY A HUMANIZED MAB TO CD2 (MEDI-507) IS MEDIATED BY NK CELLS
IMPACT OF ACUTE REJECTION THERAPY ON INFECTIONS AND MALIGNANCIES IN RENAL TRANSPLANT RECIPIENTS
EFFECT OF CYCLOSPORINE ON MYCOPHENOLIC ACID TROUGH LEVELS IN KIDNEY TRANSPLANT RECIPIENTS1
BLOOD EOSINOPHILIA IN TACROLIMUS-TREATED PATIENTS
ADENOCARCINOMA ON RENAL ALLOGRAFT AS A COMPLICATION AT 5 YEARS
LIVING RELATED LIVER TRANSPLANTATION FROM DONORS WITH THE LEFT-SIDED GALLBLADDER/PORTAL VEIN ANOMALY
CAMPATH IH ALLOWS LOW-DOSE CYCLOSPORINE MONOTHERAPY IN 31 CADAVERIC RENAL ALLOGRAFT RECIPIENTS
SUPRACELIAC AORTIC PSEUDOANEURYSMS AFTER LIVER TRANSPLANTATION IN INFANTS
DEVELOPMENT OF POLYCYSTIC DISEASE IN A KIDNEY 10 YEARS AFTER TRANSPLANTATION
ORGANTRANSPLANTATION IN RATS AND MICE
ANNOUNCEMENTS